Powerful perspectives

Industry Insight
Scientific innovation in uveal melanoma

Industry Insight
Opportunities and challenges in oncology immunotherapy

Industry Insight
Reflections from our CEO

Industry Insight
Pancreatic cancer – our commitment to scientific advances

Industry Insight
A bold new era in global cancer drug discovery

Industry Insight
A note from our CEO

Industry Insight
Realising the potential of autotaxin therapy in cancer

Industry Insight
PI3Kδ inhibitors offer serious promise in solid tumors

Industry Insight
Emerging therapies offer hope for uveal melanoma patients
All articles

The role of CAF in promoting cancer cell proliferation

iOnctura data at AACR demonstrates unique mechanism of action for clinical stage autotaxin inhibitor IOA-289

iOnctura data at AACR demonstrates unique mechanism of action for clinical stage autotaxin inhibitor IOA-289

iOnctura to present preclinical data on its clinical stage autotaxin inhibitor, IOA-289, at AACR

Looking for media
resources?